Pancreatic Cancer Research

ResearcherUniversity of FreiburgActive in the last 2 years

Michael Seifert

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2844-053X; OpenAlex author ID A5086242721. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 3

  1. GOT1 Inhibition Induces Extracellular Matrix Remodeling in Pancreatic Cancer. Co-author DOI 10.1002/advs.202516578↗
  2. A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutrophil recruitment and immunosuppression. Co-author DOI 10.1016/j.biomaterials.2025.123456↗
  3. Inducing a humoral immune response to pancreatic cancer antigen. Co-author DOI 10.1016/j.cellimm.2016.09.002↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniela Loessner · 2 shared papers, 2026 · strength 0.53
  2. Rodrigo Curvello · 1 shared paper, 2026 · strength 0.28
  3. Daniel Gerald Croagh · 1 shared paper, 2026 · strength 0.28
  4. Franziska Baenke · 1 shared paper, 2026 · strength 0.25
  5. Jens Pietzsch · 1 shared paper, 2026 · strength 0.25
  6. Verena Kast · 1 shared paper, 2026 · strength 0.25
  7. Daniel E. Stange · 1 shared paper, 2026 · strength 0.25
  8. Uwe A. Wittel · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.